Kathleen M. Whalen - Jan 30, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Ethics Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jan 30, 2023
Transactions value $
-$62,496
Form type
4
Date filed
2/1/2023, 07:07 PM
Previous filing
May 5, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Gift $0 -341 -3% $0.00 11K Jan 31, 2023 Direct
transaction HCA Common Stock Options Exercise $87K +1.25K +11.33% $69.58 12.3K Jan 31, 2023 Direct
transaction HCA Common Stock Tax liability -$149K -586 -4.77% $255.07 11.7K Feb 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +3.79K $0.00 3.79K Jan 30, 2023 Common Stock 3.79K $253.30 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -1.25K -33.24% $0.00 2.51K Jan 31, 2023 Common Stock 1.25K $69.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.